Angiotensin-converting enzyme inhibitors for ovarian cancer? - a new adjuvant option or a silent trap.
Rep Pract Oncol Radiother
; 28(4): 551-564, 2023.
Article
in En
| MEDLINE
| ID: mdl-37795232
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
Rep Pract Oncol Radiother
Year:
2023
Document type:
Article
Affiliation country: